CXCR4 and chronic obstructive pulmonary disease: HIF-1α inhibition completely abrogates the expansion of HBEC-KRASV12high CD133+ CICs induced by COPD-EVs, especially acting on CD133+CXCR4+ MICs (Fig. 4E).